Theranostic Application of a Novel G-Quadruplex-Forming DNA Aptamer Targeting Malate Synthase of Mycobacterium tuberculosis.

Mol Ther Nucleic Acids · 2019 · PMC6849348 · PMID 31704587

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

The aptamer MS10-Trunc yielded a very high sensitivity and specificity (>97%) with a highly significant discrimination ( *** p < 0.0001) between CSF from TBM and non-TBM subjects.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.